[1]
H. Y. Bako, “Impact of Tofacitinib and Aspirin on Lipoprotein Levels in Type 2 diabetic Rats: Implications for Macrovascular Complications’ Risk Mitigation”, USci, vol. 3, no. 3, pp. 159–165, Aug. 2024.